These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11266163)
1. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Runyon SP; Savage JE; Taroua M; Roth BL; Glennon RA; Westkaemper RB Bioorg Med Chem Lett; 2001 Mar; 11(5):655-8. PubMed ID: 11266163 [TBL] [Abstract][Full Text] [Related]
2. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor. Westkaemper RB; Runyon SP; Savage JE; Roth BL; Glennon RA Bioorg Med Chem Lett; 2001 Feb; 11(4):563-6. PubMed ID: 11229772 [TBL] [Abstract][Full Text] [Related]
3. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist. Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561 [TBL] [Abstract][Full Text] [Related]
4. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Runyon SP; Peddi S; Savage JE; Roth BL; Glennon RA; Westkaemper RB J Med Chem; 2002 Apr; 45(8):1656-64. PubMed ID: 11931619 [TBL] [Abstract][Full Text] [Related]
5. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands. Westkaemper RB; Glennon RA Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195 [TBL] [Abstract][Full Text] [Related]
15. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action. Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294 [TBL] [Abstract][Full Text] [Related]
16. [Synthesis and biological activities of new 5-HT2A selective ligands--N-substituted-piperidinyl-4-phenylthioether and sulfone derivatives]. Wang H; Wen R; Huang L; Bi R; Tan PZ Yao Xue Xue Bao; 2001 Apr; 36(4):274-7. PubMed ID: 12580055 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging. Fu X; Tan PZ; Kula NS; Baldessarini R; Tamagnan G; Innis RB; Baldwin RM J Med Chem; 2002 May; 45(11):2319-24. PubMed ID: 12014970 [TBL] [Abstract][Full Text] [Related]
18. Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands. El-Subbagh H; Wittig T; Decker M; Elz S; Nieger M; Lehmann J Arch Pharm (Weinheim); 2002 Nov; 335(9):443-8. PubMed ID: 12447918 [TBL] [Abstract][Full Text] [Related]
19. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity. Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083 [TBL] [Abstract][Full Text] [Related]
20. Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor. Peddi S; Roth BL; Glennon RA; Westkaemper RB Bioorg Med Chem Lett; 2003 Aug; 13(15):2565-8. PubMed ID: 12852967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]